DianaCMedgyesyMD

Physician

Overview of Dr. Medgyesy

Dr. Diana Medgyesy is an oncologist in Fort Collins, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, UCHealth Poudre Valley Hospital, UCHealth Medical Center of the Rockies, Banner McKee Medical Center, and Sidney Regional Medical Center. She received her medical degree from University of Medicine and Pharmacy Timisoara and has been in practice 26 years. Dr. Medgyesy accepts several types of health insurance, listed below. She is one of 8 doctors at Banner McKee Medical Center and one of 8 doctors at UCHealth Medical Center of the Rockies who specialize in Oncology. She has 8 publications and over 300 citings.

Office
2121 E Harmony Rd
Unit 170
Fort Collins, CO 80528
Book by Phone+1(970) 316-7745

Fax+1 970-493-3528

Education & Training

University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1997 - 2000
Quinnipiac University Frank H. Netter MD School of Medicine/St Vincent's Medical CenterResidency, Internal Medicine, 1994 - 1997
University of Medicine and Pharmacy TimisoaraClass of 1991

Certifications & Licensure

CO State Medical License 2000 - 2025
WY State Medical License 2002 - 2025
NE State Medical License 2016 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013

Clinical Trials

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
Active, not recruiting
Phase 3
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma Start of enrollment: 2009 Jul 01
Completed
Phase 2
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial Start of enrollment: 2004 Sep 21
Completed
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Start of enrollment: 2010 Apr 01
Completed
Phase 2
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Start of enrollment: 2011 Jan 01
Completed
Phase 3
S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy Start of enrollment: 2012 Feb 01
Completed
Phase 3
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma
Available
Join now to see all

Publications & Presentations

PubMed

79 citations
Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.
Paulo M. Hoff, Everardo D. Saad, Jaffer A. Ajani, Yvonne Lassere, Cynthia Wenske
Clinical Cancer Research. 2003-01-01
28 citations
Fluoropyrimidines: A Critical Evaluation
Rogelio A. Brito, Diana C. Medgyesy, Thomas H. Zukowski, Melanie E. Royce, Farhad Ravandi-Kashani
Oncology. 1999-07-01
51 citations
Sorafenib or Placebo with Either Gemcitabine or Capecitabine in Patients with HER-2–Negative Advanced Breast Cancer That Progressed during or after Bevacizumab
Lee S. Schwartzberg, Kurt W. Tauer, Robert Hermann, Grace Makari-Judson, Claudine Isaacs
Clinical Cancer Research. 2013-05-15

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Rocky Mountain Group/Indiv - HMO/Private Pay
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment